Related Experiment Video
Updated: Jun 10, 2026
11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
Using a virtual cortical module implementing a neural field model to modulate brain rhythms in Parkinson's disease.
Julien Modolo1, Basabdatta Bhattacharya, Roderick Edwards
1Department of Medical Biophysics, Lawson Health Research Institute, University of Western Ontario London, ON, Canada.
Frontiers in Neuroscience
|August 24, 2010
Summary
This study introduces a novel method for precisely controlling brain rhythms using neural field theory and a microelectrode array. The approach aims to selectively modulate targeted rhythms, like those affected in Parkinson's disease, without disrupting others.
Area of Science:
- Neuroscience
- Computational Neuroscience
- Biomedical Engineering
Background:
- Cortical rhythms play crucial roles in brain function.
- Dysregulation of cortical rhythms is implicated in neurological disorders such as Parkinson's disease.
- Current methods for modulating brain activity may lack specificity.
Purpose of the Study:
- To propose a novel method for selective modulation of cortical rhythms based on neural field theory.
- To develop a closed-loop stimulation signal that is both space- and time-dependent.
- To introduce a new class of bio-inspired neuroprosthetic devices.
Main Methods:
- Utilizing a two-dimensional microelectrode array to monitor cortical activity.
- Employing a neural field model to describe experimentally recorded brain activity.
- Designing a closed-loop stimulation signal adaptable in space and time.
Main Results:
- The proposed method allows for selective modulation of targeted cortical rhythms.
- The technique aims to avoid interference with other neural rhythms.
- A new class of neuroprosthetic devices is conceptualized as artificial neural networks.
Conclusions:
- The developed method offers a potential solution for optimizing the interaction between stimulation devices and the cortex.
- This approach may help attenuate or augment specific cortical rhythms.
- Experimental validation in Parkinson's disease patients is the next crucial step.
Related Concept Videos
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...